| Financial Year End | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.78M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | 3.48M | 440.00K | 431.00K | 357.00K | 2.14M | N/A | N/A | N/A |
| Gross Profit | -1.69M | -440.00K | -431.00K | -357.00K | -2.14M | N/A | N/A | N/A |
| Operating Expenses | 70.95M | 74.99M | 87.17M | 62.30M | 48.24M | 33.64M | 19.49M | 23.71M |
| Selling, General & Admin | 48.66M | 19.40M | 16.98M | 12.17M | 12.09M | 11.60M | 4.47M | 4.61M |
| Research & Development | 22.28M | 42.69M | 50.18M | 41.38M | 31.46M | 22.05M | 17.28M | 17.28M |
| Other Operating Expenses | -395.00K | 12.90M | 20.01M | 8.75M | 4.69M | 195.00K | -2.27M | 1.81M |
| Operating Income | -72.64M | 74.99M | -87.17M | -62.30M | -48.24M | -33.64M | -19.49M | -23.71M |
| Other Expenses / Income | 9.65M | -154.37M | -2.63M | -10.40M | 13.82M | -17.99M | 479.00K | 1.04M |
| Before Tax Income | -63.00M | -79.38M | -89.79M | -72.70M | -34.42M | -52.86M | -19.01M | -22.67M |
| Income Tax Expenses | -1.00 | 74.99M | 2.63M | 3.74M | -70.00K | 70.00K | N/A | N/A |
| Net Income | -63.00M | -154.37M | -92.42M | -76.45M | -34.35M | -52.93M | -19.01M | -22.67M |
| Interest Expenses | 7.59M | 4.38M | 2.63M | 10.64M | 3.33M | 20.26M | 319.00K | 256.00K |
| Basic Shares Outstanding | 110.05M | 63.83M | 59.25M | 43.73M | 29.46M | 5.03M | 17.97M | 24.30M |
| Diluted Shares Outstanding | 110.05M | 63.83M | 59.25M | 43.73M | 29.66M | 5.03M | 17.97M | 24.30M |
| EBITDA | -70.62M | -74.55M | -86.74M | -59.67M | -28.95M | -32.60M | -18.53M | -23.59M |
| EBITDA Margin | -3,958.46% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT | -55.41M | -74.99M | -87.17M | -62.06M | -31.10M | -32.60M | -18.69M | -22.41M |
| EBIT Margin | -3,105.89% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Financial Year End | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |